CoCensys Inc.

The Irvine biopharmaceutical company said it lost $1.1 million, or 34 cents a share, for the second quarter, compared with a net loss of $3.6 million, or $1.32 a share, for the like period last year. The net loss for the 1999 period included a restructuring charge of $2.2 million in connection with the termination of 53 of the company’s 91 employees. It also included a gain of $3.3 million on the sale of its interest in Cytovia Inc. Revenue rose 35% to $572,000.